| abstract |
The present invention relates to methods of identifying markers, specifically those markers of antigen-specific regulatory CD4+ T cells and the use of such markers for identifying antigen-specific regulatory CD4+ T cells in bulk cell populations. The invention also relates to pharmaceutical compositions comprising the regulatory CD4+ T cells so identified, and use of the regulatory CD4+ T cells for treating and/or preventing diseases such as autoimmune disease. |